Core Insights - The company, Mediwake (02159), has been focusing on the healthcare sector since its listing on the Hong Kong Stock Exchange in 2021, adapting to the transition from rapid growth to high-quality development in the medical industry [1] - Mediwake has established a strategic upgrade direction centered on "AI small models + blockchain technology," aiming to address deep-seated industry pain points through technological innovation [2] Business Foundation - The company has a strong operational foundation, serving over 3,000 tier-three medical institutions, including top hospitals like Beijing Tiantan Hospital and Fuwai Hospital, and has partnerships with 8 out of the top 10 global pharmaceutical companies [1] - The introduction of intelligent technologies has allowed Mediwake to restructure business processes significantly, optimizing personnel structure and enhancing operational efficiency [1] Technological Advancements - Mediwake has strategically iterated and transformed its technological achievements into a dual-driven direction of "AI small models + blockchain," utilizing its self-developed "Giraffe" series digital intelligence platform for deep learning and structured processing of vast medical data [2] - The integration of blockchain technology ensures data authenticity and rights, leading to the successful acquisition of a data service provider certificate [2] Future Outlook - This strategic upgrade signifies a shift from being a "medical market solution provider" to a technology enterprise focused on "AI small models + blockchain" in the healthcare industry [2] - The company plans to continue deepening its layout in AI small models and cutting-edge technologies, aiming to lead the healthcare service industry towards intelligence and precision, thereby creating incremental value for the sector [2]
麦迪卫康(02159)战略再跃升：“AI小模型+区块链”双轮驱动，重构医疗行业解决方案